CARD9调控IL-23/Th17信号通路介导银屑病发生发展的机制研究
批准号:
82103714
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
刘晓可
依托单位:
学科分类:
皮肤免疫性疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
刘晓可
中文摘要
银屑病是一种以角质形成细胞过度增殖和异常分化为主要特征的慢性炎症性皮肤病,具体发病机制不明。胱天蛋白酶募集域蛋白9(CARD9)存在于人体多种组织中(尤其高表达于树突状细胞中),被证实与自身免疫性疾病的发生明确相关。CARD9介导DCs释放的炎性介质可促进Th17细胞极化,且与皮肤损伤修复有关,而CARD9在银屑病中的作用及机制尚无报道。我们前期研究发现寻常型银屑病患者皮损CARD9表达较正常对照显著增加,CARD9敲除小鼠经咪喹莫特诱导的银屑病模型皮损严重程度、表皮增生程度及淋巴结中Th17细胞数量都较野生型明显降低。由此,我们提出CARD9调控IL-23/Th17信号通路介导角质形成细胞异常增殖,进而影响银屑病皮损形成的全新假说。本课题拟通过体内外实验阐明CARD9调控银屑病角质形成细胞异常增殖凋亡的分子机制及其对小鼠银屑病样皮损形成的影响,深入探讨CARD9在银屑病发病机制中的作用。
英文摘要
Psoriasis is a disease whose pathogenesis has not been fully elucidated, abnormal proliferation and differentiation of keratinocytes play an important role in it. Caspase recruitment domain protein 9(CARD9) exists in various tissues (especially highly expressed in dendritic cells) of the human body. In recent years, CARD9 has been found to be related to the occurrence of autoimmune diseases. The inflammatory mediators released from CARD9-induced DCs greatly prefer the polarization of Th17 cell responses. CARD9 also attributed to skin damage repair. However, whether CARD9 is involved in the occurrence and development of psoriasis has not been reported. Our previous experiments found that the expression of CARD9 was significantly increased in psoriasis patients’ skin lesions, the severity of psoriasis-like skin lesions, histopathological epidermal hyperplasia, and number of lymph node Th17 cells in CARD9 knockout mice were significantly reduced after imiquimod treatment. Therefore, we propose the hypothesis that CARD9 regulates IL-23/Th17 signaling pathway and mediates abnormal proliferation of keratinocytes, then the formation of psoriasis. Our project will elucidate the role and molecular mechanism of CARD9 in regulating the abnormal proliferation and apoptosis of keratinocytes, as well as its effect on the formation of psoriasis-like skin lesions in mice through in vivo and in vitro experiments. We will conduct a thorough discussion of the role of CARD9 in the pathogenesis of psoriasis.
银屑病是具有遗传背景的炎症性皮肤病,可累及多个系统,目前尚无根治方法,对患者和社会造成了巨大负担。目前认为,银屑病的发病机制主要由T淋巴细胞介导,朗格汉斯细胞、树突状细胞、中性粒细胞、肥大细胞和角质形成细胞等多种免疫细胞共同参与,其中IL-23/Th17细胞炎症轴发挥了关键作用。CARD9是宿主抗真菌感染免疫反应中的关键接头蛋白,其上游为能和真菌成分结合的C型凝集素受体,下游为一系列炎症通路,可以促进Th17细胞分化和IL-17分泌,从而发挥抗真菌感染的作用,而Th17和IL-17在银屑病发病机制中也起着非常重要的促炎作用。目前关于CARD9在银屑病中的作用尚不明确,因此,本研究主要关注CARD9在银屑病发生发展中的具体机制。本课题发现银屑病患者皮损中CARD9表达升高,生物制剂治疗后可降低。通过IMQ诱导的银屑病小鼠模型验证了CARD9表达升高,并且敲除CARD9可减轻IMQ诱导的银屑病样皮炎。进一步研究发现,CARD9在皮肤中主要表达在朗格汉斯细胞中,CARD9主要通过调控朗格汉斯细胞的功能参与银屑病的发生发展。本研究为未来靶向CARD9治疗银屑病提供了理论与实验依据。
国内基金
海外基金